Making Pharmaceuticals

September 18-19, 2019 | Italy

The Leading UK Pharmaceutical Exhibition & Conference. Processing, Medical Devices, Regulatory, Clinical Testing, Research & Development, Operational Excellence, Pharmaceutical Quality, Serialisation, Clinical Trial Testing, Ingredients / Excipients, Microbiology And Pharma, Pharmaceutical Engineering, Packaging & Labelling, New Technologies, Data Management

Spotlight

Alzheimer’s Disease (AD) is the most common form of dementia and accounts for 60% to 80% of dementia cases. In this progressive disease, dementia symptoms gradually worsen over a number of years. Memory loss is mild during the early stages, but individuals with late-stage Alzheimer's lose the ability to carry on a conversation and respond to their environment. The greatest known risk factor is increasing age, and the majority of people with Alzheimer's are 65 and older. That said, up to 5% of people with the disease have early onset Alzheimer's, which often appears when someone is in their 40s or 50s1. Studies indicate that people aged 65 and older survive an average of four to eight years after diagnosis of Alzheimer’s disease, yet some live as long as 20 years or more, demonstrating the slow, insidious progression of the disease.


OTHER PAST CONFERENCES

12th Annual Biomarkers and Clinical Research Congress

October 29-30, 2021 | Canada

12th Annual Biomarkers and Clinical Research Congress is anticipating participants from 40 and more countries across the globe and the two days conference will provoke plenary sessions, Keynote speeches, Poster, and Oral Presentations. This program provides two days of robust discussions on recent advancements and new strategies for development of new materials for global requirements.

3rd International Webinar on Virtual Pharma 2021

December 4-5, 2021 | USA

3rd International Conference on Virtual Pharma 2021 | IMPACT Conferences IMPACT Conferences welcomes all the participants to attend "3rd International Conference on VIRTUAL PHARMA 2021" which will be held during December 04-05, 2021.

PRE-FILLED SYRINGES AND INJECTABLE DRUG DEVICES

January 12-13, 2022 | USA

The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to aid self-administration and deliver biologics, high concentration, and large-volume drug products.

Digital Sales and Marketing for Pharma 2021

December 1-2, 2021 | USA

Marketing and Sales are undergoing a period of transformation within pharma – moving from a strategy that was predominately focused on boots on the ground to one which is smaller, leaner and ultimately more digital. With that in mind, Digital Sales and Marketing for Pharma 2021 will be focused on: Developing an effective multi-channel customer engagement strategy across both B2B and B2C channels Leveraging data and analytics to optimize marketing activities and guide marketing investment decisions Utilizing a content marketing approach in order to drive sales ready leads to your sales teams Understanding how best to utilize digital channels in a highly regulated industry Creating and executing plans for marketing and selling specialist therapies

Spotlight

Alzheimer’s Disease (AD) is the most common form of dementia and accounts for 60% to 80% of dementia cases. In this progressive disease, dementia symptoms gradually worsen over a number of years. Memory loss is mild during the early stages, but individuals with late-stage Alzheimer's lose the ability to carry on a conversation and respond to their environment. The greatest known risk factor is increasing age, and the majority of people with Alzheimer's are 65 and older. That said, up to 5% of people with the disease have early onset Alzheimer's, which often appears when someone is in their 40s or 50s1. Studies indicate that people aged 65 and older survive an average of four to eight years after diagnosis of Alzheimer’s disease, yet some live as long as 20 years or more, demonstrating the slow, insidious progression of the disease.

resources